Daiichi Sankyo: all 498 studies

Page 2 of 5. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Study of DS-5141b in Patients With Duchenne Muscular DystrophyCompletedNCT02667483Phase 1/2Results posted
• 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on MetforminCompletedNCT02647320Phase 2Results posted
• Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )TerminatedNCT02633800Phase 2Results posted
• DS-5565 Phase III Study for Renal Impairment in Japanese SubjectsCompletedNCT02607280Phase 3Results posted
• Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic StrokeCompletedNCT02586233Phase 1/2Results posted
• Study of DS-8201a in Subjects With Advanced Solid Malignant TumorsCompletedNCT02564900Phase 1Results posted
• Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney DiseaseCompletedNCT02496884Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy AdultsCompletedNCT02478281Phase 1Results posted
• Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®CompletedNCT02453334Phase 3Results posted
• A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsTerminatedNCT02452424Phase 1/2Results posted
• A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDACompletedNCT02410213Phase 2Results posted
• Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With FibromyalgiaCompletedNCT02409459Phase 2Results posted
• Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLSCompletedNCT02397057Phase 3Results posted
• Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)CompletedNCT02371369Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)TerminatedNCT02319369Phase 1Results posted
• DS-5565 Phase III Study for Post-herpetic NeuralgiaCompletedNCT02318719Not applicableResults posted
• DS-5565 Phase III Study for Diabetic Peripheral Neuropathic PainCompletedNCT02318706Phase 3Results posted
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) StudyCompletedNCT02303431Phase 1Results posted
• An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With FibromyalgiaCompletedNCT02234583Phase 3Results posted
• Treatment of Pain Associated With FibromyalgiaCompletedNCT02187471Phase 3Results posted
• Treatment of Pain Associated With FibromyalgiaCompletedNCT02187159Phase 3Results posted
• Treatment of Pain Associated With FibromyalgiaCompletedNCT02146430Phase 3Results posted
• Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)TerminatedNCT02134015Phase 3Results posted
• Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric BypassCompletedNCT02086968Phase 4Results posted
• Cancer Venous Thromboembolism (VTE)CompletedNCT02073682Phase 3Results posted
• Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)CompletedNCT02072434Phase 3Results posted
• (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD PositiveCompletedNCT02039726Phase 3Results posted
• AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) TreatmentCompletedNCT01973569Not applicableResults posted
• Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV IronCompletedNCT01950247Phase 4Results posted
• A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or LymphomasCompletedNCT01877382Phase 1Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal ImpairmentCompletedNCT01857622Phase 3Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedNCT01857583Phase 3Results posted
• A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF MelanomaTerminatedNCT01826448Phase 1Results posted
• Edoxaban in Peripheral Arterial DiseaseCompletedNCT01802775Phase 2Results posted
• A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT01790503Phase 1/2Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic DermatitisCompletedNCT01756898Phase 2Results posted
• Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior TherapyCompletedNCT01755767Phase 3Results posted
• A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein ThrombosisCompletedNCT01662908Phase 2Results posted
• Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery DiseaseCompletedNCT01587651Phase 4Results posted
• Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01565668Phase 2Results posted
• Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid TumorsCompletedNCT01525602Phase 1Results posted
• Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT01504412Phase 2Results posted
• Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)CompletedNCT01502631Phase 2Results posted
• Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)TerminatedNCT01499043Phase 2Results posted
• Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic StrokeCompletedNCT01496885Results posted
• Treatment of Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT01496365Phase 2Results posted
• Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)CompletedNCT01382901Phase 2Results posted
• Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy SubjectsCompletedNCT01365624Phase 1Results posted
• Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative PainCompletedNCT01351090Phase 2Results posted
• Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT01349049Phase 1/2Results posted
• A Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaTerminatedNCT01349036Phase 2Results posted
• Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine BleedingCompletedNCT01307007Phase 2Results posted
• Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in WomenCompletedNCT01290315Phase 2Results posted
• Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaCompletedNCT01290302Phase 1Results posted
• A Study of DS-2248 in Participants With Advanced Solid TumorsTerminatedNCT01288430Phase 1Results posted
• The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery DiseaseCompletedNCT01260584Phase 4Results posted
• Colesevelam for Children With Type 2 DiabetesCompletedNCT01258075Phase 4Results posted
• Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerTerminatedNCT01244191Phase 3Results posted
• Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01217229Phase 2Results posted
• Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT01211483Phase 1/2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
• CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01199068Phase 1Results posted
• CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01199055Phase 1Results posted
• A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01181167Phase 3Results posted
• Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedNCT01181141Phase 3Results posted
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
• Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT01101334Phase 2Results posted
• ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT01075048Phase 1/2Results posted
• ARQ 197 for Participants With Relapsed or Refractory Germ Cell TumorsTerminatedNCT01055067Phase 2Results posted
• CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver CancerCompletedNCT01033240Phase 2Results posted
• Prasugrel/Clopidogrel Maintenance Dose Washout StudyCompletedNCT01014624Phase 4Results posted
• Safety Study of PLX108-01 in Patients With Solid TumorsCompletedNCT01004861Phase 1Results posted
• Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)CompletedNCT00989261Phase 2Results posted
• Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line ChemotherapyTerminatedNCT00986440Phase 2Results posted
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
• Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)CompletedNCT00982007Phase 3Results posted
• Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal FunctionCompletedNCT00981045Phase 3Results posted
• Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line TherapyCompletedNCT00967616Phase 2Results posted
• Olmesartan Comparison to Losartan in Hypertensive SubjectsCompletedNCT00949884Phase 4Results posted
• Combination Chemotherapy With CS-1008 to Treat Ovarian CancerCompletedNCT00945191Phase 2Results posted
• Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedNCT00923091Phase 3Results posted
• Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedNCT00902538Phase 3Results posted
• Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical AssessmentsCompletedNCT00895232Phase 2Results posted
• Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential HypertensionCompletedNCT00890591Phase 4Results posted
• Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017CompletedNCT00881569Phase 1Results posted
• Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in HypertensionCompletedNCT00858702Phase 4Results posted
• Olmesartan Medoxomil Versus Losartan in Patients With HypertensionCompletedNCT00857285Phase 3Results posted
• Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial FibrillationCompletedNCT00829933Phase 2Results posted
• DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial FibrillationCompletedNCT00806624Phase 2Results posted
• Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung CancerCompletedNCT00806286Phase 2Results posted
• A Multinational Phase III Study of CS-8958 (MARVEL)CompletedNCT00803595Phase 3Results posted
• A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedNCT00791258Phase 4Results posted
• Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusCompletedNCT00789750Phase 3Results posted
• Welchol as Monotherapy for Type 2 Diabetes MellitusCompletedNCT00789737Phase 3Results posted
• Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial FibrillationCompletedNCT00781391Phase 3Results posted
• Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency AnemiaCompletedNCT00740246Phase 3Results posted
• Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric PatientsCompletedNCT00721188Phase 2Results posted
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic DermatitisCompletedNCT00717769Phase 2Results posted
• Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00704353Phase 3Results posted

← Daiichi Sankyo overview and focus areas